Format

Send to

Choose Destination
Rev Infect Dis. 1991 Jul-Aug;13 Suppl 8:S691-5.

Pharmacology of bismuth-containing compounds.

Author information

1
Department of Medicine, Prince Henry's Hospital, Melbourne, Victoria, Australia.

Abstract

Bismuth compounds have been used for more than two centuries. A review of the modes of action, pharmacokinetics, and toxicity of two commonly used compounds, colloidal bismuth subcitrate and bismuth subsalicylate, is presented. In humans bismuth toxicity is unlikely when therapeutic doses of these compounds are administered for the appropriate duration. The recent use of bismuth compounds to eradicate infection with Helicobacter pylori and to prevent travelers' diarrhea has resulted in scientific reevaluation of these agents.

PMID:
1925310
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center